Insider Stock Trading History of Nea 14 Gp, Ltd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nea 14 Gp, Ltd since year 2005. The trader's CIK number is 1551532. At the time of this reporting, Nea 14 Gp, Ltd is the 10% Owner of Adaptimmune Therapeutics Plc . (stock ticker symbol ADAP). See this page for all insider trading activities at Adaptimmune Therapeutics Plc .

Note that in the past NEA 14 GP, LTD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Nea 14 Gp, Ltd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-03-26 ADAP Adaptimmune Therapeutics Plc Buy 571,164 1.90 1,087,496
2018-03-27 ADAP Adaptimmune Therapeutics Plc Buy 6,000,000 1.92 11,502,000
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-27 TCON Tracon Pharmaceuticals, Inc. Buy 707,964 2.70 1,911,502
2018-03-22 ADAP Adaptimmune Therapeutics Plc Buy 869,574 1.90 1,655,668
2018-03-23 ADAP Adaptimmune Therapeutics Plc Buy 294,090 1.95 572,299
2018-03-21 ADAP Adaptimmune Therapeutics Plc Buy 104,844 1.81 189,872
2017-11-27 APPN Appian Corp Sale 569,620 19.49 11,101,893
2017-11-20 APPN Appian Corp Sale 2,820,516 19.49 54,971,856
2017-07-03 MRSN Mersana Therapeutics, Inc. Buy 1,000,000 15.00 15,000,000
2017-03-27 ADAP Adaptimmune Therapeutics Plc Buy 12,870,000 .70 9,009,000
2016-11-29 TCON Tracon Pharmaceuticals, Inc. Buy 869,565 5.75 4,999,998
2013-08-06 LOXO Loxo Oncology, Inc. Buy 230,769 13.00 2,999,997

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nea 14 Gp, Ltd (10% Owner of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.